Vivo CapitalInvestor Details

Get alertedif Vivo Capital makes an investment
Vivo Capital
Country:
City:
United States
Palo Alto
Industry:Other
Detailed industries:investment management
Key people
Frank KungManaging Partner
Want to know when Vivo Capital invests in a new company?
Portfolio:
Revolution Medicines Inc (2019: $100,000,000 raised)
Poseida Therapeutics Inc (2019: $142,000,000 raised)
Maculogix Inc (2019: $38,700,000 raised)
Passage Bio (2019: $115,500,000 raised)
Bolt Biotherapeutics Inc (2019: $54,000,000 raised)
Innocare (2019: $160,000,000 raised)
Terns Pharmaceuticals Inc (2018: $80,000,000 raised)
Immune-onc Therapeutics Inc (2018: $33,000,000 raised)
Airxpanders Inc (2018: $15,000,000 raised)
Tot Biopharm Company Ltd (2018: $102,000,000 raised)
Sinovac Biotech Ltd (2018: $86,730,000 raised)
Tricida Inc (2018: $222,300,000 raised)
Metacrine Inc (2018: $65,000,000 raised)
Mei Pharma (2018: $75,000,000 raised)
Crinetics Pharmaceuticals (2018: $63,500,000 raised)
Innocare (2018: $55,000,000 raised)
Tricida Inc (2017: $57,500,000 raised)
Amyris Inc (2017: $25,000,000 raised)
Homology Medicines Inc (2017: $83,500,000 raised)
Aadi Bioscience (2017: $23,000,000 raised)
Angiotech Pharmaceuticals (2017: Undisclosed raised)
Impel Neuropharma Inc (2016: $36,000,000 raised)
Biohaven Pharmaceutical Holding Company Ltd (2016: $80,000,000 raised)
Readcoor (2016: $23,000,000 raised)
Sentreheart Inc (2016: $35,000,000 raised)
Fortis Therapeutics (2016: $18,000,000 raised)
Tricida Inc (2016: $55,000,000 raised)
Kala Pharmaceuticals Inc (2016: $68,000,000 raised)
Outpost Medicine (2016: $41,000,000 raised)
Crinetics Pharmaceuticals (2015: $40,000,000 raised)
Akari Therapeutics (2015: $75,000,000 raised)
Aclaris Therapeutics Inc (2015: $40,000,000 raised)
Nexcida Therapeutics Inc (2015: $2,750,002 raised)
Regenxbio (2015: $70,500,000 raised)
Nabriva Therapeutics Ag (2015: $120,000,000 raised)
Ascendis Pharma A S (2014: $60,000,000 raised)
Coherus Biosciences Inc (2014: $55,000,000 raised)
Pronai Therapeutics Inc (2014: $59,500,000 raised)
Nora Therapeutics Inc (2014: $18,000,000 raised)
Coinvestors:
Orbimed
Ra Capital Management
Venrock
Lilly Asia Ventures
Longitude Capital
5AM Ventures
Boxer Capital Llc
Decheng Capital
Rock Springs Capital
Cormorant Asset Management
Sibling Capital Ventures
Sofinnova Ventures
Versant Ventures
ARCH Venture Partners
Adams Street Partners
Aisling Capital
Alexandria Venture Investments
Cam Capital
Deerfield
Deerfield Management
Fidelity Management & Research Company
Frazier Healthcare Partners
Janus Capital Management Llc
Limulus Venture Partners
New Enterprise Associates
Novo A/S
OrbiMed Advisors
Osage University Partners
Perceptive Advisors Llc
Polaris Partners
Sectoral Asset Management
Venrock Healthcare Capital Partners
-aperture Venture Partners
Abci Investment Management Ltd
Advantech Capital Lp
Amherst Fund Llc
Amzak Health
Aperture Venture Partners Llc
Apjohn Ventures Fund
Arrowmark Partners
Avalon Ventures
Berwind Private Equity
Biotechnology Value Fund
Biotechnology Value Fund (bvf)
Bregua Corp
Brookside Capital
Burrill & Company
CVF
Cadence Pharmaceuticals
Canaan Partners
Capital Midwest Fund
Casdin Capital
Cathay Capital
Cathay Venture
Caxton Alternative Management Lp
Ccb Capital
Celgene
Center Laboratories Group
Chengwei Capital
China Orient Asset Management (international) Holding Ltd
China Universal (cayman) Gp Ltd
Connecticut Innovations
Cormorant Capital
Cowen And Company Llc
Deerfield Management Company
Ecor1 Capital
Fidelity Biosciences
Fisk Ventures
Foresite Capital
Franklin Templeton Investments
Frazier Healthcare
Frazier Healthcare Ventures
Fung Shing Investments
Glsv
Goldman Sachs J.p Morgan Securities Llc
Grand Angels
Gso Capital Partners Lp
Hansjorg Wyss
Hansjörg Wyss
Hbm
Hbm Healthcare Investments
Hermed Capital
Hopen Life Science Ventures
Incline Therapeutics Inc
Invus
Jianxin Capital
Kkr & Co
Knoll Capital Management
Koninklijke Dsm N.v
Lilly Ventures
Limulus Venture Partner
Litmore Capital
Loyal Valley Innovation Capital
Lux Capital
Malin Corp
Maverick Ventures
Mossrock Capital Llc
NEA
Nan Fung Group
Nan Fung Life Sciences
New Leaf Venture Partners Llc
Nextech Invest Ltd
Northern Light Venture Capital
Novartis
Novartis Ag
Novartis Venture Fund
Novo Holdings
Pentwater Capital Management Lp
Phase4 Partners
Pivotal Bioventure Partners
Prospect Venture Partners
Prospect Ventures
Qvt Financial
Ra Capital
Rapha Capital Management
Rho Ventures
Roche Venture Fund
Rock Springs Capital Management
Schroder Adveq
Temasek
The Column Group
The Stanford-startx Fund
Third Rock Ventures Llc
U.s Venture Partners
Venbio
Venbio Partners
Vida Ventures
Wellcome Trust
Wellington Management
Wellington Management Company
Wellington Management Company Llp
Yuanta Financial Holdings Group
Zq Capita
Zz Capital Co
This list displays investors that took part in the same funding round as Vivo Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!